Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism

NCT02034435 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome

Interventions

OTHER: Low Salt diet plus Placebo tablet
OTHER: Low Sodium diet plus Salt tablet
DRUG: Epleronone
DRUG: Amlodipine

Sponsor

Vanderbilt University Medical Center